Farxiga Alternatives Compared
| Farxiga (dapagliflozin) | Ozempic (semaglutide) | Tirzepatide |
|
|---|
| Farxiga (dapagliflozin) | Ozempic (semaglutide) | Tirzepatide |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Farxiga is an oral medication that is used alongside diet and exercise to lower blood glucose levels in adults and children aged 10 years and older with type 2 diabetes. It may also be used to... View more |
Prescription only
Ozempic lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It is... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Diabetes - Type 2, Obstructive Sleep Apnea/Hypopnea Syndrome. Tirzepatide may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Farxiga (dapagliflozin) | More about Ozempic (semaglutide) | More about Tirzepatide | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Farxiga has an average rating of 4.7 out of 10 from a total of 159 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 46% reported a negative effect. |
Ozempic has an average rating of 6.6 out of 10 from a total of 1390 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 24% reported a negative effect. |
Tirzepatide has an average rating of 8.7 out of 10 from a total of 1481 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Farxiga prices |
View all Ozempic prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
Other semaglutide brands include: Rybelsus, Wegovy | Mounjaro, Zepbound | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
12.9 hours |
168 hours |
120 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 362 drugs are known to interact with Farxiga:
|
A total of 267 drugs are known to interact with Ozempic:
|
A total of 412 drugs are known to interact with Tirzepatide:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
January 08, 2014 |
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.